skip to primary navigationskip to content

New hope for people who suffer with IBD with the launch of a major new research resource

last modified Jan 20, 2016 10:19 AM
Dr Miles Parkes talks about the new IBD BioResource

The goal of the new IBD BioResource is to accelerate research in Crohn’s disease and Ulcerative Colitis and build on recent major advances in understanding of the genetic basis of these conditions. The IBD BioResource will be part of the NIHR BioResource – comprising volunteers from around the UK who are willing to be approached to participate in research studies and trials on the basis of their genetic make-up. The IBD BioResource is being launched for roll-out nationwide through 2016.

More can be read about the BioResource at https://bioresource.nihr.ac.uk/news/the-ibd-bioresource-translating-todays-science-into-tomorrows-treatments/

 

 

Upcoming events

Immunogenomics of Disease: Accelerating to Patient Benefit

Feb 05, 2019

Wellcome Genome Campus, UK

Upcoming events

The new Capella building- CITIID

See the home of CITIID being built in this fantastic time-lapse video. From basement to water tight in 17 months. The Capella building will be finished in 2018.

Fibroblast

‘Fibroblast’ has been developed from a conversation between Harold Offeh and Dr Alice Denton, a scientist based at the Babraham Institute and a member of the Cambridge Immunology Network. Offeh was particularly interested in the character and roles played by particular cells in the immune system, as well as the immune system’s role as a primary source of protection and care. The film takes as a starting point microscopic images of broblast cells, an area of research for Dr Denton.

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more